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ABSTRACT 
1-(3-β-D-Glucopyranosylglycer-2-yl)-6-N-(oct-2-enyl)-adipate, [orientalin, 1] was isolated as a 
new metabolite from the polar leaf extracts of Toussaintia orientalis Verdc (Annonaceae), together 
with the glycoflavonoids afzelin and quercitrin, and the indolidinoids toussaintines A-C. The 
reversed chalcones 2-hydroxy-3,4,6-trimethoxychalcone (2) and 2-hydroxy-3,4,6-
trimethoxydihydrochalcone (3), the condensed chalcone (+)-6a,12a-dihydro-6-phenyl-7-styryl-
6H,7H-[1]benzopyrano[4,3-][l]benzopyran (4), and mixtures of known triterpenoids and steroids 
were isolated from the less polar extracts of the root and stem bark of the same plant. The 
structures were established upon detailed analysis of spectroscopic data and other physical 
parameters. The chalcones exhibited antimicrobial, anti-inflammatory, antiproliferative and 
cytotoxic activity at varying efficacy levels, the r versed chalcone 2 demonstrating anti-
inflammatory potency against COX-2 enzyme that was superior to the standard drug 
Indomethacin. These results have further indicated the versatility of Annonaceae species in 
accumulating structurally varied natural products, some of them having unprecedented structures. 
 
Keywords:  Toussaintia orientalis; Annonaceae; orientalin, 1-(3-β-D-glucopyranosylglycer-2-yl)-
6-N-(oct-2-enyl)-adipate; condensed and retrochalcones; anti-inflammatory. 
 
INTRODUCTION 
In our previous paper we reported the 
isolation of unprecedented antibacterial and 
antifungal N-cinnamoyl tetraketide 
derivatives from Toussaintia orientalis 
Verdc leaves (Samwel et al. 2011). The 
investigations were prompted by the fact 
that previously we had obtained several 
antimicrobial, cytotoxic and anti-
inflammatory aristolactams, the pseudo-
nucleoside 1-(2-C-methyl-β-D-
ribofuranosyl)-uracil and other metabolites 
from the stem and root barks of that plant 
species (Odalo et al. 2010). That was an 
unprecedented isolation of a pseudo-
nucleoside from a plant source, whose 
structurally similar derivatives are known 
antiviral marine sponge metabolites (Ichiba 
et al. 1995, Searle and Molinski 1995, 
Carroll et al. 2003, De Clercq 2003) with 
their clinically used examples including the 
anti-HIV drug azidothymidine that is 
dispensed as Retrovir® (Donia and Hamann 
2003). Therefore, while carrying out 
chemical analysis of the leaves it was 
anticipated that, just as for the stem and root 
barks, the leaves would also yield the 
pseudo-nucleoside 1-(2-C-methyl-β-D-
ribofuranosyl)-uracil or related compounds. 
The presence of such bio-medically potent 
metabolites in the leaves was considered to 
have particular significance since the leaves 
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 being regenerative, could be a sustainable 
source of the compounds. 
 
However, as we reported in Samwel et al. 
(2011), neither the pseudo-nucleoside 1-(2-
C-methyl-β-D-ribofuranosyl)-uracil nor 
such similar compounds were obtained. 
Therefore, this prompted us to re-investigate 
the leaves from a new collection in order to 
establish unequivocally whether or not the 
pseudo-nucleoside or similar compounds 
were present in the leaves. Surely, even in 
the re-investigation neither the pseudo-
nucleoside nor any similar compounds were 
obtained from the leaves. Instead we have 
isolated a new metabolite 1-(3-β-D-
glucopyranosylglycer-2-yl)-6-N-(oct-2-
enyl)-adipate (1), together with the known 
glycoflavonoids afzelin and quercitrin 
(Eldahshan 2011) and the toussaintines A – 
C (Samwel et al. 2011). Furthermore, 
phytochemical investigations of less polar 
extracts of the root and stem barks yielded 
the retro-chalcones 2 and 3, the condensed 
chalcone 4 (Nkunya et al. 1993, Lien et al. 
2000), as well as a mixture of polycarpol 
and 24-methylene-lanosta-7,9(1l)-dien-3β-
ol, and that of β−sitosterol and stigmasterol 
(Jung et al. 1990, Hasan et al. 1987, 
Chaurisia and Wichtl 1987, Greca et al. 
1990), in addition to the aristolactam 
piperolactam C that we recently reported 
(Odalo et al. 2010) from the same source. 
 
We now report the isolation, structural 
determination and biosynthetic postulation 
for the formation of the new metabolite 
orientalin [1-(3-β-D-glucopyranosylglycer-
2-yl)-6-N-(oct-2-enyl)-adipate, (1)]. We 
further report the isolation, structural 
determination and biosynthetic 
considerations, antimicrobial, anti-
inflammatory, cytotoxic activity and 
antioxidant inhibition of the chalcones 2 - 4. 
 
RESULTS AND DISCUSSION 
Repeated chromatography of the 
dichloromethane and methanol extracts 
from shade dried leaves gave a yellowish 
gum, whose structure 1 was established 
based on analysis of spectroscopic data. The 
HREIMS showed molecular ion peak at m/z 
491.3840 (C23H41NO10).  The presence of 
free hydroxyl groups was deduced from the 
appearance of a broad IR band at 3394 cm-1, 
while the strong absorptions at 1730 and 
1650 cm-1 appeared in the spectrum and 
were typical for ester and amide carbonyls, 
respectively (Silverstein et al. 1981). The 
presence of secondary acyclic amide system 
was further established by the strong IR 
band due to nitrogen-hydrogen bond 
deformation at 1458 cm-1 (Kemp 1991). 
 
Both the 1H and 13C NMR spectral features 
(Table 1), as well as H/H and H/C 
interactions observed in the COSY, HSQC 
and HMBC spectra indicated the presence 
of pyranosyl (Kasai et al. 1977; Kasai et al. 
1979; Breitmaier and Voelter, 1998) and 
glyceryl units as part of the molecular 
framework of the isolated compound, the 
latter unit being linked to the former at the 
anomeric carbon through an oxygen bridge 
(HMBC). Thus, the 13C NMR spectrum 
consisted of resonances characteristic of a 
pyranosyl unit (δ 105.3, 76.8, 74.9, 72.4, 
70.2 and 62.5), the downfield shift observed 
for the sugar residue anomeric carbon signal 
(δC 105.3) and the corresponding upfield 
shift of the anomeric proton signal (δH 4.01, 
d, 6.9 Hz) being ascribed to the presence of 
a β−substituted aglycone (Kasai et al. 
1977). In addition, the 1H and 13C NMR 
spectra indicated a signal at δ 3.51 and 62.5 
respectively, which were assignable to an 
oxymethylene group. The signals appearing 
at δ 3.61 and 70.2; and 3.28-3.23, and 76.8, 
74.9 and 72.4, respectively were ascribed to 
four oxymethine units of the pyranosyl 
skeleton. 
 
Furthermore, the 1H and 13C NMR spectra 
as well as COSY and HMBC interactions 
(Fig 2) indicated the glyceryl unit (δC 70.8, 
68.7 and 64.0) to be linked to the anomeric 
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carbon through one of its terminal 
oxymethylene oxygen atoms, and to the rest 
of the molecule through the oxymethine 
oxygen, forming an ester functionality and 
hence accounting for the downfield shift of 
the glyceryl oxymethine proton signal (δ 




















































Figure 1: Chemical structures of compounds 1-5 
 
Table 1: 1H (600 MHz) and 13C (150 MHz) NMR spectral data for orientalin (1) in CD3OD". 
 
H/C δH J (Hz) δC H/C δ H J (Hz) δC 
1 - - 175.1 1′ 4.01 d, 6.9 105.3 
2 2.57 br s 35.1 2′ 3.28-3.23 m 76.8 
3 1.38 br s 26.0 3′ 3.28-3.23 m 74.1 
4 1.38 br s 26.0 4′ 3.28-3.23 m 72.4 
5 2.57 br s 34.9 5′ 3.61 br s 70.2 
6 - - 174.8 6′ 3.50 
3.52 
dd, 12.5, 3.7 
dd, 12.5, 9.8 
62.5  
7 2.80 d, J = 7.8 26.6 1′′ 4.25 dd, 12.1, 7.6 64.0 
8 5.12 br s 130.9  4.00 d, 11.7, 8.2  
9 5.12 br s 129.2 2′′ 5.02 m 71.8 
10 2.09 br s 28.2 3′′ 3.76 dd, 12.1, 4.6 68.7 
11 1.10 br s 23.8  3.51 dd, 12.1, 7.6  
12 1.10 br s 23.7     
13 1.06  br s 21.6      
14 0.68 br s 14.5     
 
br s = broad signal not well resolved to show multiplicities. 
 


















Figure 2: Important HMBC interactions observed for orientalin (1) 
 
Moreover, both the 1H and 13C NMR spectra 
(Table 1) as well as the MS fragmentation 
pattern (Scheme 1) indicated the presence of 
a 1,6-dioxohexanyl unit (δCO 175.1 and 
174.8), one side of which being linked to C-
2 (δC 70.8) of the glyceryl group through an 
oxygen bridge, and on the other side to an 
oct-2-enyl unit via an amino atom (HMBC) 
forming an amide moiety. The presence of a 
dioxohexanyl system was further deduced 
by considering the NMR signals of 
methylene units (δH 2.57, 4H; δC 35.1 and 
34.9) α to each of the two carbonyl carbons 
and their corresponding coupling 
relationships with the “middle” methylene 
moieties (COSY), and with the carbonyl 
carbons (HMBC). This was further 
corroborated by considering the 
fragmentation pattern observed in the MS 
that constituted peaks at m/z 169 and 296 
arising from McLafferty-type cleavage as 
prompted by each of the two carbonyl 
groups (Scheme 1). 
 
In addition, the 1H and 13C NMR spectra of 
1 also indicated the presence of an isolated 
N-methylene group (δH 2.80, 2H, d, J = 7.8 
Hz, and δC 26.6) adjacent to one of the two 
mutually coupling vinylic methine units (δH 
5.12, δC 130.9) of an olefinic moiety as 
deduced from 1H-1H COSY interaction. 
From the COSY and HMBC interactions it 
was evident that the above stated methylene 
unit as well as the olefinic moiety formed an 
octenyl portion of the molecule, as further 
indicated by the appearance of an MS 
fragmentation peak at m/z 111 (Scheme 1). 
Athoungh some multiplicities did not show 
the expected splitting patterns hence 
appeared as broad singlets (br s), their 
coulpling relationship were established from 
1H-1H COSY interactions. All the spectral 
features as hereby discussed established 
structure 1 for orientalin. 
 
Biosynthetically, orientalin (1) could be 
considered to belong to the series of 
nitrogenous natural products we recently 
reported from the leaves of T. orientalis, 
having been derived from a tetraketide 
parent skeleton (Samwel et al. 2011). 
However, unlike the recently reported 
nitrogenous compounds, the tetraketide 
parent skeleton in compound 1 had not 
subsequently undergone cyclization, but 
rather it formed a peptide linkage on one 
end with hexanedioic acid (adipic acid) 
derived from the oxidation of the respective 
fatty acid. Thus, the hexanedioic acid could 
then undergo or would have undergone 
glycoglycerolation on the other end to form 
structure 1. 
 
Although sugar derivatives occur as natural 
products, and previously also having been 
isolated from Annonaceae species, this is 
the first report of the natural occurrence of 
the glycerylated aminooctenyl adipate sugar 
derivative (1), and the first time to report the 
occurrence of the glycoflavanoids afzelin 
and quercitrin from T. orientalis. The 
structures of afzelin and quercitrin were 
deduced from analysis of their spectral data, 
which compared well with each other except 
for the signals appearing as the result of the 
absence of a C-3′ hydroxyl group in the 
Nyandoro et al.  – New Glucopyranosylglyceryl-N-Octenyl Adipate … 
112 
 
former compound, as further confirmed 
from the literature data (Eldahshan 2011). 
Isolation of the new metabolite (1) have 
further indicated the versatility of 
Annonaceae species in accumulating natural 
products with varied chemical structures, 
some of the metabolites constituting 
unprecedented structural frameworks 













































Scheme 1: MS fragmentation pattern for orientalin (1) 
 
The two retro-chalcones 2 and 3, and the 
condensed chalcone dependensin (4) were 
isolated upon repeated chromatography of 
the pet ether extract of the root bark of T. 
orientalis, with compound 2 being also 
obtained from the dichloromethane extract 
of the root barks. The structures of the 
compounds 2-4 were established based on 
analysis of their spectroscopic data that 
were comparable to those reported in the 
literature (Nkunya et al. 1993; Lien et al. 
2000). The co-occurrence of both 
compounds 2 and 3 is quite interesting from 
the biosynthetic point of view, although at 
this stage it is not possible to state the 
biosynthetic relationship between the two 
compounds, which would be undoubtedly 
formed more or less through the same 
sequence. Generally, chalcones are the first 
isolable compounds of the flavonoid 
biosynthesis in plants, but do not necessarily 
accumulate to any appreciable degree unless 
the enzyme chalcone isomerase, which 
catalyses the cyclization of chalcone to 
flavone, is absent (Bohm 1998). Flavonoids 
are produced from phenylpropanoid formed 
through the shikimate pathway (Hwang et 
al. 2003). Phenylalanine ammonia lyase 
(PAL) catalyzes the first committed step of 
the phenylpropanoid pathway by mediating 
the conversion of the amino acid 
phenylalanine to trans-cinnamic acid 
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 (Scheme 2). Cinnamate-4-hydroxylase 
(C4H) introduces a hydroxyl group at C-4 
of cinnamic acid in the presence of 
molecular oxygen to yield trans-4-coumaric 
acid that could also be the product of 
tyrosine ammnonia lyase (TAL) 
transformation of tyrosine formed through 
the shikimate pathway. 4-Coumarate-CoA 
ligase (4CL) activates p-coumaric acid by 
the addition of coenzyme A to produce a 4-
coumarate-CoA ester, which is the preferred 
substrate of chalcone synthase (CHS). CHS 
catalyzes the condensation of three 
molecules of malonyl-CoA with 4-
coumaryl-CoA to generate the C6- 3-C6 
skeleton found in flavonoids (Scheme 2). 
During the reaction, a tetraketide 
intermediate is formed, which then 
undergoes cyclization to 4,2',4',6'-
tetrahydroxychalcone. Retro-chalcones are 
believed to be formed from the normal 
chalcones via an intermediate 1,3-
dicarbonyl compound which could then 
undergo reduction of the carbonyl initially 
at C-l and subsequent dehydration (Saitoh et 
al. 1975). The essential features of this 1,3-
carbonyl transposition are illustrated in 
Scheme 2 for the formation of retro-
chalcones. 
 
When first isolated, dependensin was 
obtained as a racemic mixture together with 
5,7,8-trimethoxyflav-3-ene (5) and retro-
chalcone 2 (Nkunya et al. 1993). 
Dependensin was then conceived to be a 
product of non-enzymatic acid catalyzed 
dimerization of 5 while compound 2 was 
shown to be a decomposition product of 5 
(Elyashberg et al. 2002). However, 
dependensin was not detected among the 
decomposition products of 5 when the latter 
was exposed to oxygen in the presence of 
HCl, thereby indicating that despite being 
obtained in the racemic form dependensin 
isolated then was a true natural product. 
 
The fact that compound 4 was obtained in 
an optically active form in the present 
investigations, could indicate the 
participation of enzymes either in its 
biosynthesis or in kinetic resolution of the 
previously non-enzymetically formed 
racemic compound. It might also be that 
there are two enzyme systems in the two 
plant species, viz. Uvaria dependens and T. 
orientalis (both belonging to the family 
Annonaceae) for the synthesis of racemic as 
well as optically active dependensin. This is 
a subject that could only be resolved upon 
analysis of the enzyme systems found in the 
two plant species. 
 
The occurrence of a natural product both in 
a racemic and optically active form is 
unprecedented. While it is generally known 
that racemic compounds are not products of 
enzymatic reactions, the above situation 
might suggest the presence of enzymes that 
are able to facilitate kinetic resolution of a 
racemic compound such as dependensin, 
which would result from non-enzymatic 
processes to form an optically active 
compound. However, at this stage such a 
kinetic resolution process remains a subject 
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Scheme 2: Biosynthetic pathway for the formation of retro-chalcones in plants 
 
The chalcones 2-4 isolated from T. 
orientalis were evaluated for their 
antimicrobial, anti-inflammatory, cytotoxic 
activity and antioxidant inhibition. The agar 
diffusion method was used to determine 
both the antibacterial and antifungal activity 
of the compounds. Table 2 presents the 
results as zones of inhibition in the 
antimicrobial assay. The active compounds 
showed the activity in the range of 12-16 
mm. Generally, in this assay the potent 
compounds had better activity against fungi 
than bacteria. The fungal species P. notatum 
(P1) and bacterial species M. vaccae (M4) 
were more susceptible to the test 
compounds as compared to the other fungi 
and bacteria assayed. Compound 3 showed 
a broader spectrum of antimicrobial activity 
and higher potency (inhibition zone of 16 
mm) against M. vaccae (M4) than the other 
chalcones, but had lower efficacy than the 
standard drug Ciprofloxacin. 
 
Results on the inhibition of purified NAD 
(P)-linked 3α-hydroxysteroid dehdrogenase 
as exerted by the isolated compounds at 
three different concentrations (30, 3 and 0.3 
µg/ml), (IC50 values and HKI classification 
of the observed activity) are given in Table 
3. Generally, inhibition of NAD (P) linked 
3α-hydroxylsteroid dehydrogenase of rat 
liver cytosol is correlated with anti-
inflammatory activity in humans (Penning, 
1985), and therefore this test could be 
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 reliably used to evaluate potential anti-
inflammatory agents. In that test system, the 
chalcones 2-4 exhibited varying levels of 
activity, ranging from inactivity to very 
good activity. Compound 2 was the most 
active and fell into Class 3 of the Hans-
Knöll Institute (HKI) classification, this 
indicating a very good anti-inflammatory 
activity for that compound. The condensed 
chalcone 4 exhibited good activity, which 
fell in Class 2 of the above classification, 
while dihydrochalcone 3 was inactive (Class 
0). The loss of activity observed for the 
dihydrochalone 3 as compared to the 
chalcone 2 might have been due to the 
absence of a conjugated carbonyl system in 
3. This would imply the significance of this 
functionality in the anti-inflammatory 
activity as it was previously observed for 
other activities (Rodriguez et al. 1997, Ohno 
et al. 1990). 
 
The percentage inhibitions of 
cyclooxygenase (COX-1 and COX-2) 
enzyme of the isolated compounds (which 
were found to be active in the 3α-HSD 
assay) at three different concentrations (30, 
3 and 0.3 µg/ml) are given in Table 4. Of 
the tested compounds, the reversed chalcone 
2 showed potent anti-inflammatory activity 
against the COX-2 enzyme exhibiting 88% 
inhibition at 30 µg/ml concentration as 
compared to the standard drug 
Indomethacin which showed 66% inhibition 
at the same level of concentration. However, 
the compound was weakly active against 
COX-1 while the condensed chalcone 4 was 
weakly active against both COX-1 and 
COX-2. As previously stated, the difference 
in activity of the two compounds 2 and 4 
could be the result of an α,β-unsaturated 
carbonyl system in compound 2 as the 
active site, which is absent in 4 (Rodriguez 
et al. 1997, Ohno et al. 1990). 
 
It is of interest to note that the active 
compounds as hereby reported inhibited the 
expression of COX-1 and COX-2 enzymes. 
The enzyme system COX-2 is highly 
expressed in inflammed tissues and is 
predominantly associated with development 
and continuance of inflammation in tissues 
(Xie et al. 1991). The COX pathway, for 
arachidonic acid metabolism provides many 
of the necessary inflammatory biochemical 
mediators (Xie et al. 1991), leading to the 
formation of inflammatory molecules which 
can exert profound biological effects 
influencing the process of inflammation. 
Therefore, the compounds that exhibited 
potent activity against both enzyme systems 
could provide templates from which 
pharmaceutically potent COX inhibitors 
might be derived. This is therefore an 
interesting area for future research on the 
isolated compounds. 
 
When the three chalcones 2-4 were 
evaluated for their antioxidant inhibition of 
Xanthin Oxidase (XOD) and Horseradish 
Peroxidase (HRP) enzymes, the 
dihydrochalcone 3 exhibited weak 
inhibitory activity against HRP, but 
remained inactive against XOD (Table 5). 
All the other compounds were found to be 
non-inhibitors against the two enzyme 
systems at the tested concentrations. 
 
The chalcones 2 and 3 also demonstrated 
appreciable activity in the antiproliferative 
and cytotoxic tests, compound 2 being more 
active than the dihydro- analogue 3, as both 
antiproliferative and cytotoxic agents (Table 
6). As for the other activities discussed 
earlier, the observed difference in activity 
outlined the importance of the conjugated 
carbonyl system in the activity of these 
compounds as both antiproliferative and 
cytotoxic agents. The condensed chalcone 4 
exhibited weak activity as both 
antiproliferative and cytotoxic agent. 
Chalcones are reported to possess a broad 
spectrum of biological activity, among 
which are cyctotoxicity (Go et al. 2005, 
Elias et al. 1995, Beutler et al. 1993), 
antitumour (Dhar 1981, Yamamoto et al. 
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1991, Chang et al. 2000, Zi et al. 2005), 
anti-inflammatory (Won et al. 2005), 
antiprotozoal (Frölich et al. 2005, Salem 
and Werbovetz 2005, Chen et al. 1994, 
Chen et al. 1997, Liu et al. 2001, Zhai et al. 
1999), and antioxidant (Cioffi et al. 2003, 
Cuendet et al. 2000, Mohamad et al. 2004) 
activities. Thus, the biological activity 
results reported in this paper further indicate 
the great potential of the chalcones isolated 
from T. orientalis as chemotherapeutic 
agents, for which additional research could 
yield even more interesting results.  
 
Table 2: Zones of inhibition (mm) of chalcones (2-4) against bacterial and fungal strains 
given in Table 7 
 
 Compounds/Microorganisms B1 B3 B4 B9 M4 H4 H8 P1 
     2 0 0 0 0 15 0 0 15 
     3 12 0 0 0 16 0 11 15 
     4 0 0 0 0 13 0 0 15 
Ciprofloxacin (5 µg/ml) 28 18 23 22 22 -- -- -- 
Amphotericin (10 µg/ml) -- -- -- -- -- 14 20 18 
 
Table 3: Anti-inflammatory activity of chalcones (2-4) against 3α-hydroxysteroid 
dehydrogenase (% inhibition values) 
 
Compounds    30 µg/ml 3 µg/ml 0.3 µg/ml IC50 (µg/ml) HKI Class 
     2  80 51 0 3.06 3 
     3  34 0 0 --- 0 
     4  74 34 0 8.60 2 
Indomethacin  93 27 10  4.59  
 Not active (0); active (1); more active (2); highly active (3)  
 
Table 4: Anti-inflammatory activity of compounds 2 and 4 against COX-1 and COX-2 
 
Compounds Concentration % Inhibition of COX-1 and COX-2 
  (µg/ml)   COX-1   COX-2 
      2 30  50  88 
 3  32  22 
 0.3  27  13 
     4 30  34  13 
 3  29  14 
 0.3  15  13 
Indomethacin 30    66 
  3   51     
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Table 5: Horseradish Peroxidase inhibition of compound 3 
 
Compound Concentration % Activity for Category 
 (µg/ml) Positive Control (100%) (HKI) 
    
3 40 29 1 
 20 69  
 4 106  
Standard    
NAC 40 2  
 20 2  
 4 51  
 
Category 1 = Active; 3 = Very high activity 
 
 
Table 6: Antiproliferative and cytotoxic effects of chalcones (2-4) 
 
    Antiproliferative effect (µg/ml) Cytotoxic effect (µg/ml) 
Compounds L-929 (GI50)    K-562 (GI50) HeLa (CC50)   
2  9.5  11.2  15  
3  34.1  41.2  32.1  
4  >50  >50  >50  




General experimental procedures: Column 
chromatography: Silica gel 60 (Merck 230-
400 mesh) and Sephadex® LH-20 
(Pharmacia); thin layer chromatography 
(TLC): Pre-coated plates (Merck, Kieselgel 
60 F254, 0.20 mm) and visualization: 
UV/VIS and anisaldehyde spray 
reagent/heat at ca. 110 ºC; UV (λmax, nm): 
Perkin Elmer (Lambda 35) 
spectrophotometer; IR (λmax, cm-1): Perkin 
Elmer FTIR-100 spectrophotometer; 1H 
(400 and 600 MHz) and 13C (100 and 150 
MHz) NMR: Bruker Avance Topspin 
Spectrometer and CDCl3 or CD3OD as 
solvent, TMS internal standard for 1H NMR 
and solvent signal for 13C NMR; high-
resolution electron ionization mass spectra 
(HREIMS): GCT Premier TOF mass 
spectrometer, 70 eV and 180 ºC source 
temperature; optical rotations: Perkin-Elmer 
Model 241 and JASCO P-1020 
Polarimeters. 
 
Plant materials: The root and stem barks of 
T. orientalis Verdc. were collected in 
October 2004 while leaves were re-collected 
in February 2008 from Zaraninge Forest 
Reserve at the edge of Saadani National 
Park in Bagamoyo District, Tanzania and 
the plant’s identity was confirmed at the 
Herbarium of the Department of Botany, 
University of Dar es Salaam where a 
voucher specimen is preserved under 
number FMM 3330. 
 
3.3 Extraction and isolation: The air-dried 
and powdered leaves (2 Kg) were 
sequentially extracted using pet ether, 
CH2Cl2 and MeOH at RT (2 x 48 h) and 
residual solvent removed under vacuo. The 
CH2Cl2 extract (38.4 g) on repeated column 
chromatography, eluting with a gradient of 
n-hexane and EtOAc polarity increase 
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(silica gel, 25-100% v/v EtOAc/n-hexane 
gradient elution) yielded the previously 
reported indolidinoids toussaintines A – C 
(Samwel et al. 2011) and orientalin (1, 56 
mg). The MeOH extract (78.6 g) on 
repeated column chromatography (silica gel, 
25-100% v/v EtOAc/n-hexane gradient 
elution) also gave compound 1 (290 mg), 
the toussaintines A – C, as well as afzelin 
and quercitrin (Eldahshan, 2011). 
 
The air dried and powdered root and stem 
barks (each 1 Kg) were sequentially 
extracted using pet ether, dichloromethane 
and methanol at room temperature, each 
extraction lasting for three days. Removal of 
residual solvent under reduced pressure 
furnished the crude extracts (38.2 g). The 
extracts were subjected to silica gel column 
chromatography, eluting with a gradient of 
n-hexane and EtOAc, and the fractions were 
then pooled on the basis of observations 
from TLC analysis. Repeated 
chromatography of the pet ether extract of 
the root bark yielded a mixture of β-
sitosterol) and stigmasterol (Chaurisia and 
Wichtl 1987; Greca et al. 1990), a mixture 
of polycarpol and 24-methylene-lanosta-
7,9(1l)-dien-3β-ol, (Jung et al. 1990; Hasan 
et al. 1987), 2-hydroxy-3,4,6-
trimethoxychalcone (2), 2-hydroxy-3,4,6-
trimethoxydihydrochalcone (3) and (+)-
dipendensin (4, [α]D; +16.34o). The 
dichloromethane extract of the root bark on 
repeated chromatography on silica gel and 
then Sephadex® LH-20 yielded 
piperolactam C (Odalo et al. 2010), 2 and 
polycarpol, all of which were purified 
further by recrystallization from EtOAc. 
The pet ether extract of the stem bark on 
repeated chromatography yielded 
compounds 2 and polycarpol, and a mixture 
of β-sitosterol and stigmasterol, compounds 
2 and polycarpol having been recrystallized 
from MeOH and EtOAc, respectively. 
 
1-(3-β-D-Glucopyranosylglycer-2-yl)-6-N-
(oct-2-enyl)-adipate, [orientalin 1] : Light 
yellow gum; yield, 346 mg; [α]D -7.9o 
(MeOH, c 1.38); anisaldehyde – pink then 
black; IR (film), λmax cm-1 3394, 2927, 
2855, 1730, 1650 and 1458; HREIMS, m/z 
(rel. int. %) 491.3840 ([M]+, C23H41NO10), 
341 (45), 339 (43), 313 (75), 264 (41), 262 
(30), 257 (41), 245 (46), 239 (42), 229 
(100), 227 (66), 213 (30), 213 (30), 201 
(80), 185 (40), 171 (98), 155 (85), 144 (32), 
131 (34), 129 (39), 127 (53) 125 (46), 111 
(41), 109 (67) and 107 (33); 1H and 13C 
NMR: Table 1. 
 
Biological Assays 
Agar diffusion assay for anti-microbial 
activity (antibacterial and antifungal 
activity): The agar diffusion method was 
used for the determination of antibacterial 
and antifungal activity of the isolated 
compounds against the microorganisms 
listed in Table 7.1. The microorganisms 
were obtained from the Hans Knolls 
Institute for Natural Product Research and 
Infectious Biology (HKI) in Jena, Germany. 
Approximately 9 mL of Müller-Hinton agar 
for bacteria and Sabouraud Dextrose Agar 
for fungi (Oxoid, UK) were poured into 
petri dishes (9 cm in diameter) and 
inoculated with the respective test 
organisms. Wells (4 mm) were punched out 
of the solid agar using pipette tips, and 1 
mL of 50 µg/mL of the test compounds and 
control antibiotics (Ciprofloxacin, 5µg/mL 
and Amphotericin, 10 µg/mL) were placed 
in each well. The petri dishes were then 
incubated at 30 oC and 35 oC for the test 
bacterial and fungal strains, respectively, for 
20 h and the average diameter of the 
inhibition zone surrounding the wells was 
measured. 
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 Table 7: Bacterial and fungal strains used to test for efficacy of the isolated chalcones. 
 
Code Organism Name Type HKI Code 
BNA Bacillus subtilis ATTC 6633 (IMET) NA B B1 
SA Staphylococcus aureus (IMET 10760) SG511 B B3 
EC Escherichia coli SG 458 B B4 
PA Pseudomonas aeruginosa K 799/61 B B9 
MV Mycobacterium vaccae IMET 10670 B M4 
SS Sporobolomyces salmonicolor SBUG 549 F H4 
CA Candida albicans BMSY 212 F H8 
PN Penicilium notatum F P1 
B = Bacterium; F = Fungus 
 
Antiinflammatory activity [3α-
hydroxysteroid dehydrogenase (3α-HSD) 
assay: This assay was carried out following 
standard procedures as adopted from the 
literature (Penning 1985). Cell free systems 
for the determination of antiinflammatory 
and antiphlogistic activity are critical as it is 
a complex reaction of living organisms. 
Nonetheless, in vitro assays for the 
screening of inhibitors of key enzymes like 
3α-HSD and prostaglandin H synthase are 
important tools. The NAD (P)-linked 
enzyme (3α-HSD) has been purified from 
rat liver cytosol. This enzyme is known to 
catalyze the reduction of a variety of 3-
ketosteroids, for example 5α-
dihydrotestosterone (5α-androstan-17β-O-
one), 5β-dihydrocortisone (5β-pregnan-
17α,21-diol-3,11,20-trione) to the 
corresponding 3α-hydroxysteroids through 
the consumption of NADPH and, therefore, 
plays an important role in cortisone 
metabolism. The NADPH consumption is 
determined photometrically as a decrease of 
extinction at 340 nm. Indomethacin and 
Ibuprofen are used as reference compounds. 
A surprising property of the purified 
enzyme is that it is inhibited by the major 
classes of non-steroidal and steroidal anti-
inflammatory drugs in the rank order of 
their therapeutic potency. A high correlation 
exists between the logarithm of the 
concentration of drug required to produce 
50% inhibition of the purified 3α-
hydroxysteroid dehydrogenase (log IC50 
value) and the dose required to produce an 
anti-inflammatory response in humans. 
These observations led to the suggestion 
that the extent of inhibition of 3α-
hydroxysteroid dehydrogenase could be 
used to predict anti-inflammatory drug 
potency (Penning 1985). 
 
Preparation of cytosol: Adult male 
Sprague-Dawley rats (150-200 g) were 
killed by cervical dislocation. The livers 
were excised and homogenized in 3 
volumes of 50 mM Tris-HCl of pH 8.6 
containing 250 mM sucrose, 1 mM 
dithiothreitol and 1 mM EDTA. 
Homogenates were centrifuged at 100,000 x 
g for 30 min; the supernatant (cytosol; i.e. 
source of 3α-hydroxysteroid 
dehydrogenase) was used for enzyme assays 
without further processing. 
 
Preparation of purified 3α-hydroxysteroid 
dehydrogenase: A homogeneous enzyme 
was prepared according to the method 
described by Penning (1985). This enzyme 
had a final specific activity of 3.58 µmol of 
5β-dihydrocortisone reduced/min/mg of 
protein. 
 
Enzyme assays: The reduction of 5β-
dihydrocortisone was monitored by 
measuring the changes in the absorbance of 
the pyridine nucleotide at 340 nm. Each 
assay (1.0 ml) contained the following: 
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Potassium phosphate buffer (pH 6.0, 0.840 
ml of 1M), NADPH (20 µL of 9 M), 5β-
dihydrocortisone (10 µL of 5 mM), and 
acetonitrile (30 µL). The reactions were 
initiated by the addition of enzyme (30-50 
µg of cytosolic protein or 0.6 µg of purified 
enzyme), and optical density change was 
followed over a period of 5 min. Control 
incubation experiments by addition of the 
cytosol in which either 5β-dihydrocortisone 
or NADPH was absent, indicated that the 
presence of both substances was required 
before the cytosol would promote a change 
in absorbance at 340 nm. The % inhibition 
of the isolated compounds was generated at 
three different concentrations (30, 3 and 0.3 
µg/ml). Increasing amounts of the isolated 
compound were added to the standard assay 
system, and the concentration of the 
compound required to cause the rate of 5β-
dihydrocortisone reduction by 50% (IC50) 
was computed from the resulting natural 
logarithm dose-response curves. 
 
Chemiluminescent cyclooxygenase (COX) 
inhibitor assay: Two isoforms of 
cyclooxygenase (COX-1 and COX-2) are 
the rate-limiting enzymes for the 
biosynthesis of prostaglandins, this being 
the conversion of arachidonic acid to 
prostaglandin H2 molecules that are 
responsible for the progression of some 
inflammatory responses (Smith et al. 1991; 
Cao and Prescott, 2002). COX-2 is the 
inducible isoform expressed in response to 
pro-inflammatory cytokines, endotoxins and 
tumor promoters (DuBois et al. 1998) and is 
predominantly associated with inflammation 
(Pai et al. 2001). This inducible COX-2 is 
believed to be the target enzyme for the 
anti-inflammatory activity of non-steroidal 
anti-inflammatory drugs (Xie et al. 1991). 
Therefore, it was of interest to observe if the 
isolated compounds that had shown anti-
inflammatory activity in the 3α-HSD test 
had effects on these enzymes that would 
lead to pathogenic changes, if over-
expressed. The COX inhibitor assay utilizes 
the heme-catalyzed hydroperoxidase 
activity of cyclooxygenases to generate 
luminescence in the presence of a luminal-
type cyclic naphthalene hydrazide and the 
substrate arachidonic acid. Arachidonate-
induced luminescence has been shown to be 
an index of the real-time catalytic activity 
and demonstrated the turnover inactivation 
of the enzyme (Forghani et al. 1998). The 
chemiluminescent COX assay induces both 
COX-1 and COX-2 enzymes in order to 
screen isoenzyme-specific inhibitors.  
 
Preparation of reagents: All the reagents 
used were commercially obtained from 
Cayman Chemical Company in the form of 
a Chemiluminescent COX (ovine) Inhibitor 
Screening Assay kit. The assay buffer (0.1 
M Tris-HCl, pH 8) was prepared by diluting 
3 ml of commercially available assay buffer 
concentrate with 27 ml of HPLC grade 
water and stored at 4 oC. The heme solution 
was prepared by diluting 58 µl of the 
commercial heme with 942 µl of the assay 
buffer (dilute). The COX-1 and COX-2 
enzymes, which were stored at -80 oC were 
each prepared for the assay by diluting 30 l 
of enzyme with 570 µl of assay buffer 
(dilute) and stored on ice. Arachiodonic 
acid, which was used as the substrate was 
stored at -80 oC. The supplied substrate (100 
lµ) was diluted by 10µ0 µl of 0.1 M KOH 
and the resulting solution diluted with 9.8 
ml of assay buffer (dilute) to achieve a final 
concentration of 116 µM. The 
chemiluminescent substrate, which 
contained a naphthalene hydrazide solution, 
was used as supplied. 
 
Assay procedures: The assay was performed 
in triplicate at 25 oC and the test samples 
were dissolved in DMSO. Heme (10 µl), 
assay buffer (10 µl), and solvent (10 µl) 
were added to three wells, which served as 
background wells. Three other wells which 
were designated as 100% initial activity 
wells were each constituted with heme (10 
µl), enzyme (either COX-1 or COX-2, (10 
Tanz. J. Sci. 38(3), 2012 
121
 µl)), and solvent (10 µl). Three other wells, 
which served as the inhibitor wells were 
constituted with heme (10 µl), enzyme 
(either COX-1 or COX-2 (10 µl)), and test 
sample (10 µl). The assay buffer (200 µl) 
was added to all the wells. The plate was 
then inserted into the Luminometer and the 
chemiluminiscent subsrate (10 µl) dispensed 
from the Luminometer and arachidonic acid 
(50 µl) was immediately dispensed to all the 
wells and reading taken for 10 seconds per 
well. The percent inhibition of the enzymes 
was determined from the average Relative 
Luminescent Units (RLU) values as follows: 
 
  
% Inhibtion =  100 - (RLU inhibitor sample-RLU background




Antioxidant inhibition activity: The 
antioxidant tests were carried out by 
employing Xanthine-Oxidase (XOD) and 
Horseradish peroxidase (HRP) assay 
systems. XOD is an important oxidative 
enzyme, which is involved in normal 
biological processes and also in pathological 
conditions. XOD catalyses the oxidation of 
hypoxanthine, and xanthine to uric acid 
which plays a crucial role in causing gout 
(Kong et al. 2000), whereas, the generation 
of superoxide radicals (ROS, reactive 
oxygen species) are involved in many 
pathological processes such as 
inflammation, atherosclerosis, cancer and 
aging (Halliwell et al. 1992). Therefore, it 
was of interest to observe if the isolated 
compounds could affect this enzyme that 
leads to pathogenic changes, if over-
expressed. 
 
Lucegenin derived chemiluminescence 
(LDCL) was used to measure inhibition of 
XOD as described by Li et al. (1998). ROS 
reduces lucigenin by producing lucigenin 
cation radical which reacts with the 
peroxidase radical to yield an unstable 
dioxetane intermediate. The lucigenin 
dioxetane decomposes to produce two 
molecules of N-methylacridone, one of 
which is in an electronically excited state, 
which upon relaxation to the ground state 
emits a photon. The production of ROS can 
then be monitored through sensitive 
measurement of the photon emission. 
Allopurinol, which inhibits XOD activity, 
was used as a standard drug in this assay. 
XOD catalyzes the degradation of 
azothioprin, an immunosuppressant 
substance that is used after organ transplant. 
Allopurinol is used for co-medication in 
order to slow degradation of azothioprin. 
 
The assay mixtures for enzymatic system 
contained XOD (4 µg/ml) and xanthine (0.5 
mM) in air-saturated PBS (1 ml) containing 
0.1 mM diethylenetriaminepentaacetic acid 
(DTPA) and dark-adapted lucigenin (5 µL, 5 
µM). The lucigenin-derived 
chemiluminescence was monitored with a 
Luminometer at 37 oC and light emission 
was recorded after every min for 20 min, 
and was then expressed as mean arbitrary 
light units/min. The blank reaction, that is, a 
control contained all components except the 
enzyme. The concentrations of the test 
samples were 0.16, 0.8 and 4 µg/ml. 
 
N-acetylcysteine (NAC) was used as a 
standard scavenger. Thiol-containing 
molecules possess antioxidant properties 
that are of interest in the pharmacological 
inactivation of reactive oxygen species 
(ROS), particularly in the treatment of 
chronic inflammatory diseases. The in vitro 
antioxidant activity of a new agent is 
examined and compared with NAC. This 
assay was used to assess the antioxidant 
potential of the isolated compounds. 
 




phthalazinedione) and Horseradish 
peroxidase (HRP, E.C. 1.11.1.7, Grade II) 
were obtained from Boehringer Mannheim 
(Germany). Hydrogen peroxide (30%) was 
obtained from Merck (Milan, Italy) while 
Trolox (6-hydroxy-2,5,7,8-
tetramethylchroman-2-carboxylic acid, in 
pure form, >98%), was obtained from Fluka 
(Milan, Italy). All other reagents and 
compounds were of analytical-grade. All 
solutions were prepared with pyrogen-free 
reagent-grade water, using a Milli-Q system 
(Millipore, Milan, Italy). A Luminoscan 
Ascent luminometer (Labsystems, Helsinki, 
Finland) was used to perform the automated 
assays. The data were recorded using a 
computer and the Ascent software for 
kinetics measurements. The 96-wells blank 
microplates employed in the automated 
assay were from Thermo Labsystems, 
Helsinki, Finland. 
 
The reagent solutions used in the assay were 
prepared, stored and employed according to 
published literature for the 
chemiluminescent (CL) antioxidants assay 
(Girotti et al. 2002). The calibration curve 
(1–10 µM Trolox) was measured once a 
week and any time when the stable reagents 
(luminol and HRP solutions) were newly 
prepared. Otherwise, at each experimental 
session only one standard concentration was 
measured, that compared with the 
calibration curve, was used to calculate a 
“correction factor”. When this value was 
lower than 0.8 or higher than 1.2 a new 
calibration curve was prepared. In each well 
of the microplate were manually injected 10 
µl of the sample or standard solution and 20 
µl of HRP solution. The reaction started 
when 200 µl of CLM were injected 
automatically in each well. Signal intensities 
(RLU) and count numbers were 
automatically recorded.  
Antiproliferative and cytotoxicity assay: 
Antiproliferative and cytotoxic activity of 
the compounds was determined as described 
in the literature (Dahse t al. 2001). The 
compounds were assayed on cell lines K-
562 (human chronic myeloid leukaemia) and 
L-929 (mouse fibroblast) for their 
antiproliferative effects (GI50, concentration 
which inhibited cell growth by 50%), and 
against HeLa cells for their cytotoxicity 
effects (GC50 = concentration at which cells 
are destroyed by 50%; used partially in 
referring to the lysis of cells). The cells were 
incubated at 10 different concentrations of 
each of the target compounds.  Cells of 
established suspended cell lines K-562 
(DSM ACC 10) and adherent Huvec (L-929) 
were cultured in the RPMI medium (Dahse 
et al. 2001). The adherent cells of L-929 
were harvested at the logarithmic growth 
phase after trypsinization, using 0.25% 
trypsin in PBS containing 0.02% EDTA 
(Biochrom KG L2163). For each experiment 
with K-562, L-929, and HeLa cells 
approximately 10,000 cells were seeded 
with 0.1 mL RPMI 1640 (GIPCO BRL 
21875-034) containing 25 µg/ml Gentamicin 
sulfate (BioWhittaker 17-528Z but without 
HEPES) per well of the 96-well microplates 
(K-562: NUNC 163320, L-929, HeLa: 
NUNC 167008). For the cytotoxicity assay, 
the HeLa cells were pre-inoculated for 48 h 
without the test substances. The dilution of 
the compounds was carefully made on the 
monolayers of HeLa cells after the pre-
incubation time.  
Cells of L-929, K-562 and HeLa in the 
presence of the respective test compounds 
were incubated for 72 h at 37oC in a 
humidified atmosphere and 5% CO2. 
Suspension cultures of K-562 in microplates 
were analyzed by an electronic cell analyzer 
system (CASY 1, SCHÄRFE, Reutlingen, 
Germany) using an aperture of 150 µm. The 
contents of each well (0.2 ml) in the 
microplate were diluted 1:50 with 
CAYSTON (SCHÄRFE). Every count/ml 
was automatically calculated from the 
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 arithmetic mean of three successive counts 
of 0.4 ml each. From the dose response 
curves the GI50 values were calculated using 
the computer program CASYSTAT. The 
GI50 value was defined as the 50% 
intersection line of the concentration-
response curve, determined by the cell 
count/ml as compared to the control. The 
essential parameters for the estimation of 
growth inhibition and for changes in the 
diameter distribution curve were expressed 
as diagrams. The monolayer of the adherent 
Huvec (L-929) and HeLa cells were fixed 
by glutaraldehyde and stained with a 
solution of methylene blue. After washing 
gently, the stain was eluted by 0.2 ml of 
0.33 M HCl into the wells. The optical 
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